Medical Condition News

RSS

Keryx Biopharmaceuticals commences Phase 2 clinical study evaluating KRX-0401 for Chronic Lymphocytic Leukemia

Keryx Biopharmaceuticals, Inc. announced today the initiation of a Phase 2 clinical study to evaluate KRX-0401 (perifosine) as a single agent treatment for relapsed or refractory Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL).

8 Oct 2009

Epitope spreading can get triggered by live, attenuated Listeria vaccine

Advaxis, Inc. (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Lm) vaccine company, in collaboration with its scientific founder and Scientific Advisory Board Chair Dr. Yvonne Paterson, have shown that epitope spreading occurs in response to a form of the Company’s proprietary technology that targets tumor blood vessels (anti angiogenic antigen).

8 Oct 2009

BioDelivery Sciences' partner Meda to launch ONSOLIS for managing breakthrough pain

BioDelivery Sciences International, Inc. announced that its commercial partner Meda will launch the FDA-approved ONSOLIS (fentanyl buccal soluble film) next week for the management of breakthrough pain (BTP) in patients with cancer, eighteen years of age and older, who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.

8 Oct 2009

Kaiser Permanente launches osteoporosis prevention campaign

Encouraging everyone to “Embrace Your Inner Strength,” Kaiser Permanente has launched a campaign throughout Southern California aimed at getting teenagers, seniors and everyone in between to get serious about building up their skeletons and preventing osteoporosis.

8 Oct 2009

New Everyware Medical Gateway solution to remotely monitor treatment for diabetic patients

Eurotech Group, a leading supplier of embedded technologies, products, and systems, announces today the Everyware(TM) Medical Gateway designed to help physicians remotely monitor and adjust the treatment of their diabetes patients.

8 Oct 2009

Macuclear and Mystic announce groundbreaking results from Phase Ib Clinical Trial for Macular Degeneration

MacuCLEAR, Inc. and Mystic Pharmaceuticals, Inc., announced today preliminary successful results of a Phase Ib Clinical Trial for the treatment and prevention of the progression of Age Related Macular Degeneration (AMD). The preliminary results indicated that MacuCLEAR’s MC-1101 drug is safe and well tolerated by study participants, and has a biological effect on blood flow in the back of the retina.

8 Oct 2009

Human stem cells advance cancer vaccine research

Scientists from the United States and China have revealed the potential for human stem cells to provide a vaccination against colon cancer, reports a study published in STEM CELLS.

8 Oct 2009

New Leaf Brands' initiative to find cure for MS, will sponsor a participating team for bike ride event

New Leaf Brands, a wholly owned subsidiary of Baywood International, Inc. (OTCBB: BAYW) ("Company"), today announced that the Company will sponsor a participating team in the Multiple Sclerosis/Tappan Zee Bike Ride taking place on Sunday, October 18, 2009 in Tarrytown, New York.

8 Oct 2009

Team PHLY to play against 'Big 5' to raise money for American Cancer Society

Philadelphia Insurance Companies (PHLY) will kick-off basketball season by facing the city of Philadelphia's "Big 5" college basketball coaches on the court at the University of Pennsylvania's Palestra Saturday, October 10, 2009 at 6:30 p.m. Team PHLY will tip-off against Coaches Fran Dunphy (Temple), Phil Martelli (Saint Joseph's), Bruiser Flint (Drexel), John Giannini (La Salle), Glen Miller (University of Pennsylvania) and Jay Wright (Villanova) to raise money for the American Cancer Society.

8 Oct 2009

Elderly cancer patients need custom-made treatment to combat the disease

Elderly cancer patients need a combination of treatments tailor-made to their specific needs to successfully combat the disease. The challenge is to boost their immune response to cancer vaccines, because like the rest of our organs, our immune system ages and gradually becomes less efficient as we get older.

8 Oct 2009

Clinical and health status outcomes information repository of heart attack patients completed

An important observational registry evaluating processes of care and one-year outcomes of over 4300 heart attack patients is now being completed. Researchers at the Saint Luke's Mid America Heart Institute in Kansas City, MO have led this observational research study in collaboration with 23 other hospitals throughout the U.S.

8 Oct 2009

Mitraclip is an experimental and controversial procedure, says heart specialist

Seventy-seven year-old Hollywood legend Elizabeth Taylor announced on Tuesday she was having a Mitraclip heart procedure. Leading cardiothoracic surgeon and heart surgery expert Dr. Lishan Aklog, M.D. appeared on EmpowHer, the home of women's health online, to explain why her surgery is "experimental and controversial."

8 Oct 2009

Ipsen and Spirogen sign new licensing agreement for development of SJG-136 anticancer agent

Ipsen and Spirogen Ltd. announced today that the parties have entered into a new agreement superseding their 2003 contractual relationship regarding the DNA minor groove binder SJG-136 (now known as SG2000).

8 Oct 2009

Quest Diagnostics' DNA testing for gene variants help improve outcomes for stent recipients

DNA testing for gene variants that can increase the risk of major coronary events in certain patients taking the anti-clotting drug Plavix® (clopidogrel bisulfate) is now being performed by Quest Diagnostics for Scripps Health patients electing to undergo coronary stent procedures.

From Quest Diagnostics 8 Oct 2009

BUSM researchers identify genes that influence the onset age of Parkinson's Disease

Researchers from Boston University School of Medicine (BUSM) have identified genes which may influence the onset age of Parkinson's Disease (PD). The findings, which currently appear on-line in BMC Medical Genetics, are the first to identify genes contributing to the variation in onset age and may help identify mechanisms and therapeutic targets capable of delaying symptoms.

8 Oct 2009

New results support rapid blood pressure treatment for patients with hemorrhagic stroke

New results support that treatment for hemorrhagic stroke can be improved by using medication to rapidly reduce blood pressure. Hemorrhagic stroke is a type of stroke that involves bleeding in the brain. About 35,000 patients a year in the United States have hemorrhagic stroke with corresponding high blood pressure.

8 Oct 2009

Researchers find link between obesity and common mental disorders

Doctors should pay more attention to the link between common mental illness and obesity in patients because the two health problems are closely linked, according to researchers at the University of Adelaide.

8 Oct 2009

Lions Eye Institute for Transplant & Research to study vision impairment and blindness

Real-time biomedical studies of factors leading to vision impairment are now possible through the world's largest ocular research center at Lions Eye Institute for Transplant & Research.

8 Oct 2009

AMAG Pharmaceuticals to present three abstracts at ASN Renal Week meeting

AMAG Pharmaceuticals, Inc. today announced that three abstracts have been accepted for presentation at the American Society of Nephrology (ASN) Renal Week meeting being held October 27-November 1, 2009 in San Diego, CA.

8 Oct 2009

PP5 enzyme decrease in neurons can cause cell death in Alzheimer's disease patients

A Purdue University researcher has discovered that the amount of an enzyme present in neurons can affect the mechanism thought to cause cell death in Alzheimer's disease patients and may have applications for other diseases such as stroke and heart attack.

8 Oct 2009

Medical Condition News

Keryx Biopharmaceuticals commences Phase 2 clinical study evaluating KRX-0401 for Chronic Lymphocytic Leukemia

Epitope spreading can get triggered by live, attenuated Listeria vaccine

BioDelivery Sciences' partner Meda to launch ONSOLIS for managing breakthrough pain

Kaiser Permanente launches osteoporosis prevention campaign

New Everyware Medical Gateway solution to remotely monitor treatment for diabetic patients

Macuclear and Mystic announce groundbreaking results from Phase Ib Clinical Trial for Macular Degeneration

Human stem cells advance cancer vaccine research

New Leaf Brands' initiative to find cure for MS, will sponsor a participating team for bike ride event

Team PHLY to play against 'Big 5' to raise money for American Cancer Society

Elderly cancer patients need custom-made treatment to combat the disease

Clinical and health status outcomes information repository of heart attack patients completed

Mitraclip is an experimental and controversial procedure, says heart specialist

Ipsen and Spirogen sign new licensing agreement for development of SJG-136 anticancer agent

Quest Diagnostics' DNA testing for gene variants help improve outcomes for stent recipients

BUSM researchers identify genes that influence the onset age of Parkinson's Disease

New results support rapid blood pressure treatment for patients with hemorrhagic stroke

Researchers find link between obesity and common mental disorders

Lions Eye Institute for Transplant & Research to study vision impairment and blindness

AMAG Pharmaceuticals to present three abstracts at ASN Renal Week meeting

PP5 enzyme decrease in neurons can cause cell death in Alzheimer's disease patients

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Latest News